Status:
WITHDRAWN
Evaluation of Seelens AF, an Aspheric Intra-ocular Lens
Lead Sponsor:
Hanita Lenses
Conditions:
Cataract
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Senile cataract is managed by cataract extraction and intra-ocular lens (IOL) implantation. The purpose of this study is to evaluate the safety and efficacy of the SeeLens AF, an acrylic hydrophilic a...
Eligibility Criteria
Inclusion
- Senile Cataract
- Age \>18 years
- Cataract extraction using phacoemulsification
- Corneal incision less than 1.5 mm
Exclusion
- Allergy/sensitivity to eye drops used during and after cataract surgery
- Amblyopia/ strabismus
- Ocular disease, other than cataract, diminishing visual acuity, such as corneal opacity, advanced glaucoma, diabetic retinopathy, exudative or moderate to severe non-exudative age-related macular degeneration, uveitis.
- previous ocular surgery or ocular trauma in the investigated eye
- Ocular anomaly, such as microphthalmos
- Keratometry values less than 40 diopters or more than 47 diopters.
- Ocular axial length less than 21.0 mm or longer than 25.0 mm
- Intra-operative complications prior to intraocular lens implantation, such as tear of the posterior capsule.
- posterior capsular scar
- visual acuity in the fellow eye less than 20/200
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00825747
Start Date
January 1 2009
End Date
January 1 2010
Last Update
April 13 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheba, Israel, 84101
2
Meir Medical Center
Kfar Saba, Israel, 44410